Lupin informs about press release

20 May 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, use of Honeywell’s Solstice Air (HFO-1234ze cGMP) propellant by the Company, to transform respiratory care through the development of next-generation inhalers.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2099.55 -13.40 (-0.63%)
29-Dec-2025 10:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.70
Dr. Reddys Lab 1264.20
Cipla 1502.50
Zydus Lifesciences 905.80
Lupin 2099.55
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×